Increased peripheral TREM2+ expression and nonclassical monocytes combined with reductions in classical monocytes and CD16+ NK cells may represent a protective effect in neurodegenerative disease, while the opposite patterns may contribute to accelerated clinical decline. This evidence concerns the gene TREM2 and neurodegenerative disease.